Basal Cell Carcinoma Clinical Trials

28 recruiting

Basal Cell Carcinoma Trials at a Glance

45 actively recruiting trials for basal cell carcinoma are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Phase 2 with 17 trials, with the heaviest enrollment activity in New York, Miami, and Columbus. Lead sponsors running basal cell carcinoma studies include Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Maastricht University Medical Center, and Mayo Clinic.

Browse basal cell carcinoma trials by phase

Treatments under study

About Basal Cell Carcinoma Clinical Trials

Looking for clinical trials for Basal Cell Carcinoma? There are currently 28 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Basal Cell Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Basal Cell Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 45 trials

Recruiting
Phase 1Phase 2

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+10 more
National Cancer Institute (NCI)16 enrolled26 locationsNCT05896839
Recruiting
Phase 2

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins57 enrolled1 locationNCT03521830
Recruiting

Familial Investigations of Childhood Cancer Predisposition

Hereditary Breast and Ovarian CancerHodgkin LymphomaAdrenocortical Carcinoma+30 more
St. Jude Children's Research Hospital1,500 enrolled1 locationNCT03050268
Recruiting
Phase 2

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Advanced Colorectal CarcinomaAdvanced Anal CarcinomaAdvanced Biliary Tract Carcinoma+41 more
Mayo Clinic220 enrolled2 locationsNCT05969860
Recruiting
Not Applicable

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

Skin Basal Cell Carcinoma
University of Michigan Rogel Cancer Center200 enrolled1 locationNCT06539468
Recruiting
Early Phase 1

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

Advanced Basal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute34 enrolled1 locationNCT05651828
Recruiting

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Locally Advanced Merkel Cell CarcinomaLocally Advanced Mucosal MelanomaClinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center70 enrolled1 locationNCT07215988
Recruiting
Phase 2

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
Thomas Jefferson University70 enrolled3 locationsNCT05929664
Recruiting
Phase 2

Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients

Basal Cell Carcinoma (BCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest34 enrolled7 locationsNCT06981325
Recruiting
Phase 1Phase 2

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

CancerMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune, Inc.90 enrolled28 locationsNCT04349436
Recruiting
Early Phase 1

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Skin Squamous Cell CarcinomaSkin Basal Cell CarcinomaSkin Nodular Basal Cell Carcinoma
Kirsten Johnson40 enrolled1 locationNCT07144384
Recruiting
Phase 2

Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

Basal Cell Carcinoma
University of California, San Diego30 enrolled3 locationsNCT06624475
Recruiting
Not Applicable

Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas

Basal Cell Carcinoma
Roswell Park Cancer Institute60 enrolled1 locationNCT07182240
Recruiting
Phase 3

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

Nodular Basal Cell Carcinoma of Skin
University of Sao Paulo142 enrolled1 locationNCT07381972
Recruiting
Phase 1

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Basal Cell Carcinoma (BCC)
Nathalie Zeitouni20 enrolled1 locationNCT06623201
Recruiting
Phase 2

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Breast CarcinomaUrothelial CarcinomaOvarian Carcinoma+26 more
Mayo Clinic27 enrolled1 locationNCT07285044
Recruiting

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Skin CancerMelanoma (Skin Cancer)Merkel Cell Carcinoma of Skin+3 more
University of Wisconsin, Madison20 enrolled1 locationNCT06608511
Recruiting
Phase 1

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

MelanomaHead and Neck Squamous Cell CarcinomaMetastatic Cancer+16 more
Memorial Sloan Kettering Cancer Center56 enrolled7 locationsNCT05859074
Recruiting
Phase 1Phase 2

Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma

Cutaneous Basal Cell Carcinoma
Instituto Oncológico Dr Rosell18 enrolled4 locationsNCT07251413
Recruiting
Phase 2Phase 3

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

Superficial Basal Cell CarcinomaSquamous Cell Carcinoma in Situ
Boston University200 enrolled1 locationNCT05381597